Reduction of brain beta-amyloid (Abeta) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Abeta clearance
M.J., J.N., M.S.K., K.A., K.M.B., E.D.G., M.G., L.L.G., L.M.H., G.M., L.M.N., M.S.P., A.-S.S
Pathway 2: Glucagon-Receptor-Mediated Hepatic Effects Glucagon receptor activation increases hepatic glucose production and upregulates cytochrome P450 activity, particularly CYP3A4 and CYP2C9
In this case, the antagonistic effect of KYNA on QA is insufficient, weakening the brain's defense against excitotoxicity
Radi, R., Oxygen radicals, nitric oxide, and peroxynitrite: Redox pathways in molecular medicine, PNAS USA , 2018, vol
Both deliver real, clinically proven results